{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T21:40:06Z","timestamp":1768340406587,"version":"3.49.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T00:00:00Z","timestamp":1736380800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T00:00:00Z","timestamp":1736380800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"The Startup Fund for Scientific Research, Fujian Medical University","award":["2018QH1022"],"award-info":[{"award-number":["2018QH1022"]}]},{"name":"the Natural Science Funding of Fujian Province","award":["2023J01677"],"award-info":[{"award-number":["2023J01677"]}]},{"DOI":"10.13039\/501100012232","name":"National Key Clinical Specialty Discipline Construction Program","doi-asserted-by":"crossref","award":["2021-76"],"award-info":[{"award-number":["2021-76"]}],"id":[{"id":"10.13039\/501100012232","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Fujian Provincial Clinical Research Center for Hematological Malignancies","award":["2020Y2006"],"award-info":[{"award-number":["2020Y2006"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Protoplasma"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s00709-024-02023-z","type":"journal-article","created":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T08:15:35Z","timestamp":1736410535000},"page":"635-647","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["SQSTM1\/p62 predicts prognosis and upregulates the transcription of CCND1 to promote proliferation in mantle cell lymphoma"],"prefix":"10.1007","volume":"262","author":[{"given":"Shuxia","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feichao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruolan","family":"You","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiqi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9411-1427","authenticated-orcid":false,"given":"Yuanzhong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,9]]},"reference":[{"key":"2023_CR1","doi-asserted-by":"publisher","unstructured":"Armitage JO, Longo DL. (2022) Mantle-cell lymphoma. N Engl J Med 386:2495\u2013506.https:\/\/doi.org\/10.1056\/NEJMra2202672","DOI":"10.1056\/NEJMra2202672"},{"key":"2023_CR2","doi-asserted-by":"publisher","first-page":"2726","DOI":"10.1182\/blood.V84.8.2726.2726","volume":"84","author":"F Bosch","year":"1994","unstructured":"Bosch F, Jares P, Campo E et al (1994) PRAD-1\/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma. Blood 84:2726\u20132732","journal-title":"Blood"},{"key":"2023_CR3","doi-asserted-by":"publisher","first-page":"3471","DOI":"10.1158\/1078-0432.Ccr-14-0620","volume":"21","author":"C Burdelski","year":"2015","unstructured":"Burdelski C, Reiswich V, Hube-Magg C et al (2015) Cytoplasmic accumulation of sequestosome 1 (p62) is a predictor of biochemical recurrence, rapid tumor cell proliferation, and genomic instability in prostate cancer. Clin Cancer Res 21:3471\u20133479. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-14-0620","journal-title":"Clin Cancer Res"},{"key":"2023_CR4","doi-asserted-by":"publisher","DOI":"10.2174\/0115680096265253231022185008","author":"X Chen","year":"2023","unstructured":"Chen X, Ye F, He H et al (2023) Denosumab induces neoplastic stromal cell apoptosis via p62 downregulation dependent on autophagy pathway in giant cell tumour of Bone. Curr Cancer Drug Targets. https:\/\/doi.org\/10.2174\/0115680096265253231022185008","journal-title":"Curr Cancer Drug Targets"},{"key":"2023_CR5","doi-asserted-by":"publisher","first-page":"10135","DOI":"10.1021\/acs.jmedchem.9b02038","volume":"63","author":"Y Chen","year":"2020","unstructured":"Chen Y, Li Q, Li Q et al (2020) p62\/SQSTM1, a central but unexploited target: advances in its physiological\/pathogenic functions and small molecular modulators. J Med Chem 63:10135\u201310157. https:\/\/doi.org\/10.1021\/acs.jmedchem.9b02038","journal-title":"J Med Chem"},{"key":"2023_CR6","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1158\/1078-0432.Ccr-20-2868","volume":"27","author":"S Demajo","year":"2021","unstructured":"Demajo S, Albero R, Clot G et al (2021) A cyclin D1-dependent transcriptional program predicts clinical outcome in mantle cell lymphoma. Clin Cancer Res 27:213\u2013225. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-20-2868","journal-title":"Clin Cancer Res"},{"key":"2023_CR7","doi-asserted-by":"publisher","first-page":"e408","DOI":"10.3324\/haematol.2019.237073","volume":"105","author":"C Fuster","year":"2020","unstructured":"Fuster C, Mart\u00edn-Garcia D, Balagu\u00e9 O et al (2020) Cryptic insertions of the immunoglobulin light chain enhancer region near CCND1 in t(11;14)-negative mantle cell lymphoma. Haematologica 105:e408\u2013e411. https:\/\/doi.org\/10.3324\/haematol.2019.237073","journal-title":"Haematologica"},{"key":"2023_CR8","doi-asserted-by":"publisher","unstructured":"Glorieux C, Enriquez C, Gonzalez G et al (2024) The multifaceted roles of Nrf2 in cancer: friend or foe? Antioxidants (Basel) 13(1):https:\/\/doi.org\/10.3390\/antiox13010070","DOI":"10.3390\/antiox13010070"},{"key":"2023_CR9","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1111\/j.1349-7006.2012.02216.x","volume":"103","author":"D Inoue","year":"2012","unstructured":"Inoue D, Suzuki T, Mitsuishi Y et al (2012) Accumulation of p62\/SQSTM1 is associated with poor prognosis in patients with lung adenocarcinoma. Cancer Sci 103:760\u2013766. https:\/\/doi.org\/10.1111\/j.1349-7006.2012.02216.x","journal-title":"Cancer Sci"},{"key":"2023_CR10","doi-asserted-by":"publisher","first-page":"e74398","DOI":"10.1371\/journal.pone.0074398","volume":"8","author":"T Inui","year":"2013","unstructured":"Inui T, Chano T, Takikita-Suzuki M, Nishikawa M, Yamamoto G, Okabe H (2013) Association of p62\/SQSTM1 excess and oral carcinogenesis. PLoS ONE 8:e74398. https:\/\/doi.org\/10.1371\/journal.pone.0074398","journal-title":"PLoS ONE"},{"key":"2023_CR11","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.1016\/j.ajpath.2015.05.008","volume":"185","author":"R Iwadate","year":"2015","unstructured":"Iwadate R, Inoue J, Tsuda H et al (2015) High expression of p62 protein is associated with poor prognosis and aggressive phenotypes in endometrial cancer. Am J Pathol 185:2523\u20132533. https:\/\/doi.org\/10.1016\/j.ajpath.2015.05.008","journal-title":"Am J Pathol"},{"key":"2023_CR12","doi-asserted-by":"publisher","first-page":"22576","DOI":"10.1074\/jbc.M110.118976","volume":"285","author":"A Jain","year":"2010","unstructured":"Jain A, Lamark T, Sj\u00f8ttem E et al (2010) p62\/SQSTM1 is a target gene for transcription factor NRF2 and creates a positive feedback loop by inducing antioxidant response element-driven gene transcription. J Biol Chem 285:22576\u201322591. https:\/\/doi.org\/10.1074\/jbc.M110.118976","journal-title":"J Biol Chem"},{"key":"2023_CR13","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1002\/ajh.25487","volume":"94","author":"P Jain","year":"2019","unstructured":"Jain P, Wang M (2019) Mantle cell lymphoma: 2019 update on the diagnosis, pathogenesis, prognostication, and management. Am J Hematol 94:710\u2013725. https:\/\/doi.org\/10.1002\/ajh.25487","journal-title":"Am J Hematol"},{"key":"2023_CR14","doi-asserted-by":"publisher","first-page":"3416","DOI":"10.1172\/jci61272","volume":"122","author":"P Jares","year":"2012","unstructured":"Jares P, Colomer D, Campo E (2012) Molecular pathogenesis of mantle cell lymphoma. J Clin Invest 122:3416\u20133423. https:\/\/doi.org\/10.1172\/jci61272","journal-title":"J Clin Invest"},{"key":"2023_CR15","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1111\/codi.15486","volume":"23","author":"T Kobayashi","year":"2021","unstructured":"Kobayashi T, Ishida M, Miki H et al (2021) p62 is a useful predictive marker for tumour regression after chemoradiation therapy in patients with advanced rectal cancer: an immunohistochemical study. Colorectal Dis 23:1083\u20131090. https:\/\/doi.org\/10.1111\/codi.15486","journal-title":"Colorectal Dis"},{"key":"2023_CR16","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/ncb2021","volume":"12","author":"M Komatsu","year":"2010","unstructured":"Komatsu M, Kurokawa H, Waguri S et al (2010) The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1. Nat Cell Biol 12:213\u2013223. https:\/\/doi.org\/10.1038\/ncb2021","journal-title":"Nat Cell Biol"},{"key":"2023_CR17","doi-asserted-by":"publisher","first-page":"3275","DOI":"10.1128\/mcb.00248-10","volume":"30","author":"A Lau","year":"2010","unstructured":"Lau A, Wang XJ, Zhao F et al (2010) A noncanonical mechanism of Nrf2 activation by autophagy deficiency: direct interaction between Keap1 and p62. Mol Cell Biol 30:3275\u20133285. https:\/\/doi.org\/10.1128\/mcb.00248-10","journal-title":"Mol Cell Biol"},{"key":"2023_CR18","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1128\/mcb.00620-10","volume":"31","author":"JF Linares","year":"2011","unstructured":"Linares JF, Amanchy R, Greis K, Diaz-Meco MT, Moscat J (2011) Phosphorylation of p62 by cdk1 controls the timely transit of cells through mitosis and tumor cell proliferation. Mol Cell Biol 31:105\u2013117. https:\/\/doi.org\/10.1128\/mcb.00620-10","journal-title":"Mol Cell Biol"},{"key":"2023_CR19","doi-asserted-by":"publisher","unstructured":"Lu J, Ding Y, Zhang W et al (2023) SQSTM1\/p62 knockout by using the CRISPR\/Cas9 system inhibits migration and invasion of hepatocellular carcinoma. Cells 12:https:\/\/doi.org\/10.3390\/cells12091238","DOI":"10.3390\/cells12091238"},{"key":"2023_CR20","doi-asserted-by":"publisher","unstructured":"Lu T, Zhang J, McCracken J et al (2024) Recent advances in genomics and the therapeutics in mantle cell lymphoma. Cancer Treat Rev 122:102651: https:\/\/doi.org\/10.1016\/j.ctrv.2023.102651","DOI":"10.1016\/j.ctrv.2023.102651"},{"key":"2023_CR21","doi-asserted-by":"publisher","first-page":"9889","DOI":"10.3892\/ol.2018.8579","volume":"15","author":"Y Lu","year":"2018","unstructured":"Lu Y, Wang Q, Zhou Y et al (2018) Overexpression of p62 is associated with poor prognosis and aggressive phenotypes in osteosarcoma. Oncol Lett 15:9889\u20139895. https:\/\/doi.org\/10.3892\/ol.2018.8579","journal-title":"Oncol Lett"},{"key":"2023_CR22","doi-asserted-by":"publisher","first-page":"883","DOI":"10.2147\/ott.S46222","volume":"6","author":"RZ Luo","year":"2013","unstructured":"Luo RZ, Yuan ZY, Li M, Xi SY, Fu J, He J (2013) Accumulation of p62 is associated with poor prognosis in patients with triple-negative breast cancer. Onco Targets Ther 6:883\u2013888. https:\/\/doi.org\/10.2147\/ott.S46222","journal-title":"Onco Targets Ther"},{"key":"2023_CR23","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1046\/j.1365-2141.1996.d01-1675.x","volume":"93","author":"M Monteil","year":"1996","unstructured":"Monteil M, Callanan M, Dascalescu C, Sotto JJ, Leroux D (1996) Molecular diagnosis of t(11;14) in mantle cell lymphoma using two-colour interphase fluorescence in situ hybridization. Br J Haematol 93:656\u2013660. https:\/\/doi.org\/10.1046\/j.1365-2141.1996.d01-1675.x","journal-title":"Br J Haematol"},{"key":"2023_CR24","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023022241","author":"MHA Morsy","year":"2024","unstructured":"Morsy MHA, Lilienthal IL, M, et al (2024) SOX11 is a novel binding partner and endogenous inhibitor of SAMHD1 ara-CTPase activity in mantle cell lymphoma. Blood. https:\/\/doi.org\/10.1182\/blood.2023022241","journal-title":"Blood"},{"key":"2023_CR25","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1182\/blood.2020005289","volume":"136","author":"F Nadeu","year":"2020","unstructured":"Nadeu F, Martin-Garcia D, Clot G et al (2020) Genomic and epigenomic insights into the origin, pathogenesis, and clinical behavior of mantle cell lymphoma subtypes. Blood 136:1419\u20131432. https:\/\/doi.org\/10.1182\/blood.2020005289","journal-title":"Blood"},{"key":"2023_CR26","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1182\/blood-2018-02-833475","volume":"133","author":"TD Nguyen","year":"2019","unstructured":"Nguyen TD, Shaid S, Vakhrusheva O et al (2019) Loss of the selective autophagy receptor p62 impairs murine myeloid leukemia progression and mitophagy. Blood 133:168\u2013179. https:\/\/doi.org\/10.1182\/blood-2018-02-833475","journal-title":"Blood"},{"key":"2023_CR27","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/1755-8166-4-8","volume":"4","author":"CK Rocha","year":"2011","unstructured":"Rocha CK, Praulich I, Gehrke I, Hallek M, Kreuzer KA (2011) A rare case of t (11;22) in a mantle cell lymphoma like B-cell neoplasia resulting in a fusion of IGL and CCND1: case report. Mol Cytogenet 4:8. https:\/\/doi.org\/10.1186\/1755-8166-4-8","journal-title":"Mol Cytogenet"},{"key":"2023_CR28","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/hep.28251","volume":"63","author":"X Sun","year":"2016","unstructured":"Sun X, Ou Z, Chen R et al (2016) Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells. Hepatology 63:173\u2013184. https:\/\/doi.org\/10.1002\/hep.28251","journal-title":"Hepatology"},{"key":"2023_CR29","doi-asserted-by":"publisher","unstructured":"Tang J, Li Y, Xia S et al (2021) Sequestosome 1\/p62: A multitasker in the regulation of malignant tumor aggression (Review). Int J Oncol 59(4). https:\/\/doi.org\/10.3892\/ijo.2021.5257","DOI":"10.3892\/ijo.2021.5257"},{"key":"2023_CR30","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1056\/NEJMoa1306220","volume":"369","author":"ML Wang","year":"2013","unstructured":"Wang ML, Rule S, Martin P et al (2013) Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma. N Engl J Med 369:507\u2013516. https:\/\/doi.org\/10.1056\/NEJMoa1306220","journal-title":"N Engl J Med"},{"key":"2023_CR31","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1038\/sj.leu.2403459","volume":"18","author":"I Wlodarska","year":"2004","unstructured":"Wlodarska I, Meeus P, Stul M et al (2004) Variant t(2;11)(p11;q13) associated with the IgK-CCND1 rearrangement is a recurrent translocation in leukemic small-cell B-non-Hodgkin lymphoma. Leukemia 18:1705\u20131710. https:\/\/doi.org\/10.1038\/sj.leu.2403459","journal-title":"Leukemia"},{"key":"2023_CR32","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/hep.29781","volume":"68","author":"SY Wu","year":"2018","unstructured":"Wu SY, Lan SH, Wu SR et al (2018) Hepatocellular carcinoma-related cyclin D1 is selectively regulated by autophagy degradation system. Hepatology 68:141\u2013154. https:\/\/doi.org\/10.1002\/hep.29781","journal-title":"Hepatology"},{"key":"2023_CR33","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/ajcp\/aqz133","volume":"153","author":"J Zhou","year":"2020","unstructured":"Zhou J, Hu L, Zuo M, Zhou Y, Li G, Zhang X (2020) An uncommon case of double-hit mantle cell lymphoma that demonstrates a transformation process. Am J Clin Pathol 153:49\u201357. https:\/\/doi.org\/10.1093\/ajcp\/aqz133","journal-title":"Am J Clin Pathol"}],"container-title":["Protoplasma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00709-024-02023-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00709-024-02023-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00709-024-02023-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T06:55:10Z","timestamp":1745391310000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00709-024-02023-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,9]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["2023"],"URL":"https:\/\/doi.org\/10.1007\/s00709-024-02023-z","relation":{},"ISSN":["0033-183X","1615-6102"],"issn-type":[{"value":"0033-183X","type":"print"},{"value":"1615-6102","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,9]]},"assertion":[{"value":"6 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Human subjects: All patients gave informed consent for participation, and the protocol for the present study was approved by the ethics committee of the Fujian Medical University Union Hospital (2018KY69).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}]}}